Custom service

Peptide Nucleic Acids Synthesis

Synthesize pna oligomers, including modified and conjugated formats

Turnaround: 4–7 weeksTypical scale: 0.1 mg – 10 g per sequenceChemistry options: PNA solid-phase synthesis; backbone and base modifications; peptide–PNA conjugation

Peptide Nucleic Acids Synthesis supports programmes that synthesize PNA oligomers, including modified and conjugated formats. In a typical engagement we plan the PNA solid-phase synthesis route first, confirm compatibility with backbone and base modifications, and release PNA oligomer with HPLC/MS and Tm data on a 4–7 weeks schedule.

Chemistry is chosen for the molecule, not from a menu. Where the payload tolerates it we keep PNA solid-phase synthesis as the primary option and hold backbone and base modifications in reserve, so that scale-up never depends on an unproven step.

High-affinity diagnostic probes

Antisense research constructs

GMP PNA supply

Sequences where a recombinant expression route is objectively cheaper and faster

Release specification is fixed at quotation: standard >95% by HPLC, >98% for assay-critical material. Long chains (>60 residues) are additionally confirmed by MS/MS sequence coverage, and truncated-deletion species are quantified, not just summarized.

Service Highlights

  • PNA solid-phase synthesis as the default route, with backbone and base modifications held as a proven fallback
  • Peptide–PNA conjugation worked into the design where the application requires it
  • Sequence difficulty analysis (aggregation risk, motif hazards) is done before synthesis, and the route is chosen around it
  • Analytical confirmation of every intermediate before the final release
  • Microwave-assisted coupling and double-coupling are applied automatically where the sequence demands them
  • PNA oligomer with HPLC/MS and Tm data delivered with a complete conjugation or synthesis certificate

How the work runs

  1. Sequence analysis

    Peptide Nucleic Acids Synthesis is analyzed for aggregation risk, motif hazards and puri?cation difficulty before a route is quoted.

  2. Route selection

    Fmoc solid-phase, fragment ligation or hybrid solution-phase is selected and documented.

  3. Assembly

    The chain is built with PNA solid-phase synthesis applied where the sequence demands it, with double-coupling at hazard sites.

  4. Cleavage & crude QC

    Crude material is characterized so purification targets are set on data, not hope.

  5. Purification

    RP-HPLC (and ion-exchange where needed) delivers the agreed purity; fractions are pooled on MS confirmation.

  6. Release

    PNA oligomer with HPLC/MS and Tm data is documented with the full analytical package and released.

Specifications & timeline

Turnaround
4–7 weeks
Typical scale
0.1 mg – 10 g per sequence
Chemistry options
PNA solid-phase synthesis; backbone and base modifications; peptide–PNA conjugation
Deliverable
PNA oligomer with HPLC/MS and Tm data
QC package
HPLC purity, ESI/MALDI MS, MS/MS confirmation for long chains
Shipping
Ambient with desiccant; blue ice for modified or sensitive peptides

Related Products

Next step

Tell us the target, we will tell you what is feasible

Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.